Skip to main content
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 1997 Mar 1;88(2):99–104. doi: 10.1007/BF03403870

Kidney Cancer in Canada: The Rapidly Increasing Incidence of Adenocarcinoma in Adults and Seniors

Shiliang Liu 1, Robert Semenciw 1, Howard Morrison 1, Dena Schanzer 1, Yang Mao 1,
PMCID: PMC6990164  PMID: 9170688

Abstract

Purpose: To examine kidney cancer incidence and mortality patterns since 1969 in Canada.

Method: Linear regression of the log rates was used to estimate secular trends by age group and sex, and age-period-cohort models were fitted to examine changes in kidney cancer and renal adenocarcinoma incidence rates.

Results: A substantial increase in incidence rates was observed among those 35 years and older, with average increases of 2.5% or more annually for both sexes. Age-period-cohort modelling suggested that much of this increase resulted from a period effect. Changes in mortality were much more modest, especially among those aged 0–34, for whom mortality rates actually declined by an average of 4.2% and 5.4% annually for males and females respectively.

Conclusions: Kidney cancer incidence rates have increased significantly, especially renal adenocarcinoma among adults and seniors. Diagnostic improvements and increasing levels of obesity in the Canadian population may have contributed to these trends.

References

  • 1.Coleman MP, Estève J, Damiecki P K u organs I, et al., editors. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121. Lyon: International Agency for Research on Cancer; 1993. pp. 577–99. [DOI] [PubMed] [Google Scholar]
  • 2.Higginson J, Muir CS, Munõz N K pelvis I, editors. Human Cancer: Epidemiology and Environmental Causes. Cambridge: Cambridge University Press; 1992. pp. 425–30. [Google Scholar]
  • 3.Richie JP, et al. Neoplasms of the genitourinary tract. In: Holland JF, Bast RC, Kufe DW, et al., editors. Cancer Medicine. 3rd Edition. 1993. pp. 1529–38. [Google Scholar]
  • 4.National Cancer Institute of Canada NCIC. Canadian Cancer Statistics. Toronto: NCIC; 1996. pp. 15–46. [Google Scholar]
  • 5.World Health Organization. International Classification of Diseases, 1975. Geneva: WHO; 1977. [Google Scholar]
  • 6.World Health Organization. International Classification of Diseases for Oncology. Geneva: WHO; 1976. [Google Scholar]
  • 7.Davis DL, Dinse GE, Hoel DG. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987—good news and bad news. JAMA. 1994;271:431–37. doi: 10.1001/jama.1994.03510300037035. [DOI] [PubMed] [Google Scholar]
  • 8.Clayton D, Schifflers E. Models for temporal variation in cancer rates, I: Age-period and age-cohort models. Stat Med. 1987;6:449–67. doi: 10.1002/sim.4780060405. [DOI] [PubMed] [Google Scholar]
  • 9.Clayton D, Schifflers E. Models for temporal variation in cancer rates, II: Age-period-cohort models. Stat Med. 1987;6:469–81. doi: 10.1002/sim.4780060406. [DOI] [PubMed] [Google Scholar]
  • 10.SAS Institute Inc. SAS/STAT Software: Changes and enhancements through release 6.11. 1996. [Google Scholar]
  • 11.Gloeckler Ries LA, Miller BA, Hankery BF, et al., editors. SEER Cancer Statistics Review 1973–1991. Bethesda, MD: National Institutes of Health; 1994. pp. 203–15. [Google Scholar]
  • 12.Smith SJ, Bosniak MA, Megibow AJ, et al. Renal cell carcinoma: Earlier discovery and increased detection. Radiology. 1989;170:699–703. doi: 10.1148/radiology.170.3.2644658. [DOI] [PubMed] [Google Scholar]
  • 13.Tosaka A, Ohya K, Yamada K, et al. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultra-sonography. J Urol. 1990;144:1097–99. doi: 10.1016/S0022-5347(17)39667-2. [DOI] [PubMed] [Google Scholar]
  • 14.Aso Y, Homma Y. A survey on incidental renal cell carcinoma in Japan. J Urol. 1992;147:340–43. doi: 10.1016/S0022-5347(17)37231-2. [DOI] [PubMed] [Google Scholar]
  • 15.Lanctin HP, Futter NG. Renal cell carcinoma: Incidental detection. Can J Surg. 1990;33:488–90. [PubMed] [Google Scholar]
  • 16.Rousseau T, Peyret C, Zerbib M, et al. Circumstances of the detection of kidney cancer. Current part of accidental discoveries. J Urol (Paris) 1994;100:189–95. [PubMed] [Google Scholar]
  • 17.Homma Y, Kawabe K, Kitamura T, et al. Increased incidental detection and reduced mortality in renal cancer—recent retrospective analysis at eight institutions. Int J Urol. 1995;2:77–80. doi: 10.1111/j.1442-2042.1995.tb00428.x. [DOI] [PubMed] [Google Scholar]
  • 18.Sasaki Y, Homma Y, Hosaka Y, et al. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection. Jpn J Clin Oncol. 1994;24:32–36. [PubMed] [Google Scholar]
  • 19.Bennington JL. Cancer of the kidney-etiology, epidemiology, and pathology. Cancer. 1973;32:1017–22. doi: 10.1002/1097-0142(197311)32:5<1017::AID-CNCR2820320501>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  • 20.Statistics Canada. Health Status of Canadians: Report of the 1991 General Social Survey. Ottawa: Statistics Canada; 1994. pp. 77–154. [Google Scholar]
  • 21.Benhamou S, Lenfant MH, Ory-Paoletti C, et al. Risk factors for renal-cell carcinoma in a French case-control study. Int J Cancer. 1993;55:32–36. doi: 10.1002/ijc.2910550107. [DOI] [PubMed] [Google Scholar]
  • 22.Yu MC, Mack TM, Hanisch R, et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. JNCI. 1986;77:351–56. [PubMed] [Google Scholar]
  • 23.Kreiger N, Marrett LD, Dodds L, et al. Risk factors for renal cell carcinoma: Results of a population-based case-control study. Cancer Causes Control. 1993;4:101–10. doi: 10.1007/BF00053150. [DOI] [PubMed] [Google Scholar]
  • 24.Mclaughlin JK, Gao YT, Gao RN, et al. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer. 1992;52:562–65. doi: 10.1002/ijc.2910520411. [DOI] [PubMed] [Google Scholar]
  • 25.Mellemgaard A, Møller H, Olsen JH, et al. Increased risk of renal cell carcinoma among obese women. JNCI. 1991;83:1581–82. doi: 10.1093/jnci/83.21.1581. [DOI] [PubMed] [Google Scholar]
  • 26.MacDougall ML, Welling LW, Wiegmann TB. Renal adenocarcinoma and acquired cystic disease in chronic hemodialysis patients. Am J Kidney Dis. 1987;9:166–71. doi: 10.1016/S0272-6386(87)80094-X. [DOI] [PubMed] [Google Scholar]
  • 27.Canadian Institute for Health Information. Canadian Organ Replacement Register, 1993 Annual Report. Don Mills, Ontario: CIHI; 1995. pp. 109–12. [Google Scholar]
  • 28.International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, some pharmaceutical drugs. Lyon: IARC; 1980. pp. 135–61. [Google Scholar]
  • 29.Ross RK, Paganini-Hill A, Landolph J, et al. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res. 1989;49:1045–48. [PubMed] [Google Scholar]
  • 30.Mclaughlin JK, Blot WJ, Mehl ES, et al. Relation of analgesic use to renal cancer: Population-based findings. Natl Cancer Inst Monogr. 1985;69:217–22. [PubMed] [Google Scholar]
  • 31.McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer. 1988;42:13–16. doi: 10.1002/ijc.2910420104. [DOI] [PubMed] [Google Scholar]
  • 32.Maclure M, MacMahon B. Phenacetin and cancers of the urinary tract. N Engl J Med. 1985;313:1479. doi: 10.1056/NEJM198512053132316. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES